Brokerages Set agilon health, inc. (NYSE:AGL) Target Price at $7.81

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been given an average recommendation of "Hold" by the twenty brokerages that are currently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, thirteen have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $7.81.

A number of brokerages have weighed in on AGL. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Benchmark reiterated a "buy" rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Citigroup reiterated a "sell" rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday, October 29th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday, August 9th.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 3.20% of the company's stock.

Institutional Investors Weigh In On agilon health

Institutional investors have recently modified their holdings of the business. J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after acquiring an additional 3,625 shares during the period. CWM LLC lifted its position in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new stake in agilon health during the second quarter worth about $60,000. Bleakley Financial Group LLC bought a new stake in agilon health during the first quarter worth about $65,000. Finally, Allspring Global Investments Holdings LLC lifted its position in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock worth $70,000 after purchasing an additional 10,674 shares during the period.

agilon health Trading Up 2.2 %

agilon health stock traded up $0.06 during midday trading on Tuesday, hitting $2.73. 3,245,169 shares of the stock were exchanged, compared to its average volume of 4,879,542. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a 52 week low of $2.36 and a 52 week high of $15.12. The company has a fifty day simple moving average of $3.39 and a two-hundred day simple moving average of $5.05. The stock has a market capitalization of $1.12 billion, a PE ratio of -3.74 and a beta of 0.60.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted ($0.04) earnings per share. The business's revenue was up 38.7% on a year-over-year basis. Equities research analysts anticipate that agilon health will post -0.32 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.